Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 35 | 34 | 2007 | 2019 | ||||||||
|
aldehyde dehydrogenase 1 family member A2 | 0.578 | 0.692 | 0.36 |
|
phenotype | 0.100 | None | 1.000 | 34 | 26 | 2008 | 2019 | ||||||||
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
phenotype | 0.100 | None | 1.000 | 33 | 7 | 2007 | 2019 | ||||||||
|
solute carrier family 2 member 9 | 0.619 | 0.731 | 6.9E-10 |
|
phenotype | 0.100 | None | 1.000 | 33 | 30 | 2007 | 2019 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
phenotype | 0.100 | None | 1.000 | 27 | 20 | 2008 | 2019 | ||||||||
|
ZPR1 zinc finger | 0.674 | 0.462 | 8.9E-09 |
|
phenotype | 0.100 | None | 1.000 | 27 | 13 | 2008 | 2019 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
phenotype | 0.100 | None | 1.000 | 21 | 15 | 2008 | 2019 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
phenotype | 0.100 | None | 1.000 | 20 | 27 | 2008 | 2019 | ||||||||
|
lipase C, hepatic type | 0.585 | 0.654 | 3.3E-07 |
|
phenotype | 0.100 | None | 1.000 | 20 | 10 | 2008 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.100 | None | 1.000 | 19 | 9 | 2009 | 2019 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
phenotype | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
zinc finger and BTB domain containing 38 | 0.663 | 0.615 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 18 | 12 | 2008 | 2019 | ||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | ||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | ||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | ||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | ||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | ||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
disease | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 |